Bioanalysis of GLP-1 Analog Drugs in Clinical Pharmacokinetic (PK) Studies For the bioanalysis of GLP-1 analog drugs in clinical PK samples, like other peptide/protein drugs, two commonly used methods are ligand binding assay (LBA) and liquid chromatography-mass spectrometry (LC-MS/MS)
However, recent reports, heralded by a CNN story published on July 25, have highlighted several cases of persistent vomiting and "stomach paralysis" in people who take the drugs
A comprehensive meta-analysis of 47 randomized, controlled trials encompassing more than 23,000 participants found that GLP-1 receptor agonists led to significant reductions in body weight, body mass index (BMI) and waist circumference compared to placebo
Overall, regulation of DPP-4 remains nebulous
While this side effect is often temporary and manageable, understanding how to support your gut is crucial for a smoother and more comfortable experience on your weight loss journey with prescription GLP-1 medications for obesity
doi: 10.26355/eurrev_202012_24046 142 KhanmohammadiS.RezaeiN